Can a daily nudge cut deadly bloodstream infections?
NCT ID NCT07746674
First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time
Summary
This study tests whether a daily electronic alert can help reduce unnecessary use of central venous catheters (CVCs) in hospitalized adults. The alert flags patients with an active CVC but no documented reason for it, prompting the care team to reassess and document whether the line is still needed. The goal is to reduce the number of days patients have a central line without a clear indication, thereby lowering the risk of central line-associated bloodstream infections (CLABSI). The trial compares this alert intervention to usual care in a small group of adult patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- A daily electronic health record alert prompting clinicians to document the necessity of a central line
- What this could lead to
- If effective, this simple alert could reduce unnecessary central line days and lower the risk of serious bloodstream infections in hospitals.
- What could go wrong
- The trial is small and early, and the alert's impact may be limited by clinician adherence or existing practices. It may not generalize to all hospital settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL LINE-ASSOCIATED BLOODSTREAM INFECTION (CLABSI) are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NYU Langone Health
New York, New York, 10016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.